NALOXONE HCI
NALOXONE HCI is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including NALOXONE HCI. Available dosage form: injection, solution.
Drug Details
- Generic Name
- NALOXONE HCI
- Brand Names
- NALOXONE HCI
- Application Number
- ANDA070256
- Sponsor
- HF Acquisition Co. LLC, DBA Health First
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS & USAGE NARCAN Nasal Spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. NARCAN Nasal Spray is intended for immediate administration as emergency therapy in settings where opioids may be present. NARCAN Nasal Spray is not a substitute for emergency medical care. Limitations of Use: Restrict prescription of NARCAN Nasal Spray 2 mg to opioid-dependent patients expected to be at risk for severe opioid withdrawal in situations where there is a low risk for accidental or intentional opioid exposure by household contacts.